TRENDING TOPICS
3286 articles found for "investing"
Sequoia and Accel-backed life insurance platform Ethos Technologies prices IPO at $18-$20 per share, aiming to raise up to $211 million when it lists on NASDAQ January 29.
UnitedHealth stock down 34.5% in past year as medical care ratio hits 89.9%. Investors await Tuesday's Q4 results amid questions about cost pressures.
3M posts Q4 EPS of $1.83 beating estimates as the industrial giant emerges from $16 billion in legal settlements. Stock has rallied 33% in past year.
Booz Allen Hamilton posts Q4 EPS of $1.77, beating estimates by 39%, as government consulting giant benefits from strong federal contract demand.
Analysts across Wall Street cut Netflix price targets by up to 19% despite a narrow Q4 beat, citing Warner Bros. acquisition concerns and slowing engagement metrics.
The final GDP estimate for Q3 2025 shows the US economy expanded at a 4.4% annualized rate, beating expectations. Atlanta Fed's GDPNow model projects even stronger Q4 growth.
Intuitive Surgical reports Q4 earnings of $2.53 per share, beating estimates by 12%, as the company's next-generation Da Vinci 5 surgical robot sees explosive adoption.
Meta stock jumps after Jefferies reiterates buy rating and $910 target, citing attractive risk-reward following 18% pullback and upcoming Q4 earnings catalyst.
GE Aerospace reports Q4 earnings of $1.57 per share, beating estimates by $0.13, with revenue up 17.6%. Despite strong results and $190B backlog, shares fall on profit-taking.
3M reports Q4 adjusted EPS of $1.83 beating estimates, projects 4% sales growth and $8.50-$8.70 EPS for 2026 as innovation pipeline accelerates under CEO William Brown.
Eli Lilly has invested $409 million in AI drug discovery through Genetic Leap and is building the most powerful supercomputer in pharmaceutical history with NVIDIA.
3M reports Q4 2025 earnings January 20 with analysts expecting $1.82 EPS, up 8.3% year-over-year. Here's why the industrial giant's results matter for the broader economy.